CDK10/cyclin M is a protein kinase that controls ETS2 degradation and is deficient in STAR syndrome

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 48, 2013, Pages 19525-19530

  Guen, Vincent J ^a   Gamble, Carly ^a   Flajolet, Marc ^b   Unger, Sheila ^c   Thollet, Aurélie ^d,e   Ferandin, Yoan ^a   Superti Furga, Andrea ^c   Cohen, Pascale A ^d,e   Meijer, Laurent ^a,f   Colas, Pierre ^a  

^a CNRS   (France)

^b ROCKEFELLER UNIVERSITY   (United States)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d UNIVERSITÉ LYON 1   (France)

^e INSERM   (France)

^f Centre de Perharidy   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 10; CYCLIN M PROTEIN; CYCLINE; ETS2 PROTEIN; PROTEASOME; TAMOXIFEN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY MALFORMATION; MUTANT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; RNA SPLICING; STAR SYNDROME; SYNDACTYLY; TELECANTHUS;

ANAL CANAL; BLOTTING, WESTERN; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASES; CYCLINS; HEK293 CELLS; HUMANS; HYPERTELORISM; IMMUNOPRECIPITATION; KIDNEY; MCF-7 CELLS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; PROTO-ONCOGENE PROTEIN C-ETS-2; SYNDACTYLY; TOES; TWO-HYBRID SYSTEM TECHNIQUES; UROGENITAL ABNORMALITIES;

EID: 84888363600     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1306814110     Document Type: Article

References (27)

1. Malumbres M, Barbacid M (2009) Cell cycle, CDKs and cancer: A changing paradigm. Nat Rev Cancer 9(3): 153-166.
2. Malumbres M, et al. (2009) Cyclin-dependent kinases: A family portrait. Nat Cell Biol 11(11): 1275-1276.
3. Graña X, Claudio PP, De Luca A, Sang N, Giordano A (1994) PISSLRE, a human novel CDC2-related protein kinase. Oncogene 9(7): 2097-2103.
4. Brambilla R, Draetta G (1994) Molecular cloning of PISSLRE, a novel putative member of the cdk family of protein serine/threonine kinases. Oncogene 9(10): 3037-3041.
5. Li S, et al. (1995) The cdc-2-related kinase, PISSLRE, is essential for cell growth and acts in G2 phase of the cell cycle. Cancer Res 55(18): 3992-3995.
6. Iorns E, et al. (2008) Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer. Cancer Cell 13(2): 91-104.
7. Yu JH, et al. (2012) CDK10 functions as a tumor suppressor gene and regulates survivability of biliary tract cancer cells. Oncol Rep 27(4): 1266-1276.
8. Zhong XY, et al. (2012) Clinical and biological significance of Cdk10 in hepatocellular carcinoma. Gene 498(1): 68-74.
9. Kasten M, Giordano A (2001) Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity. Oncogene 20(15): 1832-1838.
10. Unger S, et al. (2008) Mutations in the cyclin family member FAM58A cause an Xlinked dominant disorder characterized by syndactyly, telecanthus and anogenital and renal malformations. Nat Genet 40(3): 287-289.
11. Murray AW, Marks D (2001) Can sequencing shed light on cell cycling? Nature 409(6822): 844-846.
12. van den Heuvel S, Harlow E (1993) Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262(5142): 2050-2054.
13. Li M, et al. (2008) The adaptor protein of the anaphase promoting complex Cdh1 is essential in maintaining replicative lifespan and in learning and memory. Nat Cell Biol 10(9): 1083-1089.
14. Hunter T (2007) The age of crosstalk: Phosphorylation, ubiquitination, and beyond. Mol Cell 28(5): 730-738.
15. Loyer P, et al. (2008) Characterization of cyclin L1 and L2 interactions with CDK11 and splicing factors: Influence of cyclin L isoforms on splice site selection. J Biol Chem 283(12): 7721-7732.
16. Crawford J, et al. (1999) The PISSLRE gene: Structure, exon skipping, and exclusion as tumor suppressor in breast cancer. Genomics 56(1): 90-97.
17. Sergère JC, Thuret JY, Le Roux G, Carosella ED, Leteurtre F (2000) Human CDK10 gene isoforms. Biochem Biophys Res Commun 276(1): 271-277.
18. Khanal P, et al. (2012) Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells. Oncogene 31(34): 3845-3856.
19. Barette C, Jariel-Encontre I, Piechaczyk M, Piette J (2001) Human cyclin C protein is stabilized by its associated kinase cdk8, independently of its catalytic activity. Oncogene 20(5): 551-562.
20. Larochelle S, et al. (2006) Dichotomous but stringent substrate selection by the dualfunction Cdk7 complex revealed by chemical genetics. Nat Struct Mol Biol 13(1): 55-62.
21. Emanuele MJ, et al. (2011) Global identification of modular cullin-RING ligase substrates. Cell 147(2): 459-474.
22. Raouf A, Seth A (2000) Ets transcription factors and targets in osteogenesis. Oncogene 19(55): 6455-6463.
23. Dwyer JM, Liu JP (2010) Ets2 transcription factor, telomerase activity and breast cancer. Clin Exp Pharmacol Physiol 37(1): 83-87.
24. Sumarsono SH, et al. (1996) Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice. Nature 379(6565): 534-537.
25. Threadgill DW (2008) Down's syndrome: Paradox of a tumour repressor. Nature 451(7174): 21-22.
26. Rakenius A, et al. (2010) STAR syndrome and nephroblastoma-FAM58A linking organogenesis and tumorigenesis? Eur J Pediatr 169:389.
27. Bickle MBT, Dusserre E, Moncorgé O, Bottin H, Colas P (2006) Selection and characterization of large collections of peptide aptamers through optimized yeast twohybrid procedures. Nat Protoc 1(3): 1066-1091.